4
12
N. Kanomata et al. / Tetrahedron Letters 50 (2009) 409–412
6
.
(a) Kosmrlj, J.; Weigel, L. O.; Evans, D. A.; Downey, C. W.; Wu, J. J. Am. Chem. Soc.
003, 125, 3208–3209; (b) Kolarovic, A.; Berkes, D. A.; Baran, P.; Povazanec, F.
Tetrahedron Lett. 2005, 46, 975–978; (c) Berkes, D.; Jakubec, P.; Winklerova, D.;
Povazanec, F.; Daich, A. Org. Biomol. Chem. 2007, 5, 121–124.
27.5, 26.8, 26.4, 26.38, 26.3, 25.3, 25.2, 24.8, 24.7, 24.5, 10.4; CD (CH
ext = 283 (
ꢂ18.4), 261 (ꢂ1.3), 230 (ꢂ40.1), 203.7 (+20.5).
p
13. HPLC analysis showed that the final mixture contained 96.9% of (R )-5b,
3
CN):
2
k
De
0
p
,3 S,R
0 0 0
p p p p p p
1.5% of (S ,3 S,R )-5b, 0.9% of (S ,3 S,S )-5b, and 0.7% of (R ,3 S,S )-5b (column:
7
8
.
.
Ueda, T.; Kanomata, N.; Machida, H. Org. Lett. 2005, 7, 2365–2368.
(a) Kanomata, N.; Yamada, S.; Ohhama, T.; Fusano, A.; Ochiai, Y.; Oikawa, J.;
Yamaguchi, M.; Sudo, F. Tetrahedron 2006, 62, 4128–41338; (b) Kanomata, N.;
Nakata, T. J. Am. Chem. Soc. 2000, 122, 4563–4568; Kanomata, N.; Nakata, T.
Angew. Chem., Int. Ed. 1997, 36, 1207–1211.
Chiralcel OD, Dicel Chemical Industries, Ltd; Mobile phase: 5% IPA in hexane;
flow rate: 2.0 mL/min; oven temperature: 25 °C).
14. (a) Kanomata, N.; Maruyama, S.; Tomono, K.; Anada, S. Tetrahedron Lett. 2003,
44, 3599–3603; (b) Miao, R.; Zheng, Q.-Y.; Chen, C.-F.; Huang, Z.-T. J. Org. Chem.
2005, 70, 7662–7671.
15. CD spectral data for (S
0
9
.
Kanomata, N.; Ochiai, Y. Tetrahedron Lett. 2001, 42, 1045–1048.
p
, 4 S)-3b: CD (CH
3
CN): kext = 283 (
D
e
+8.4), 261 (+2.2),
ꢂ6.9),
0
1
0. Kanomata, N.; Oikawa, J. Tetrahedron Lett. 2003, 44, 3625–3628.
232 (+23.6), 203 (ꢂ24.5). For (R
p
, 4 S)-3b: CD (CH
3
CN): kext = 283 (De
1
1. (a) Kanomata, N.; Yamaguchi, M.; Mishima, G., unpublished results.; (b)
Kanomata, N. J. Synth. Org. Chem. Jpn. (Yuki Gosei Kagaku Kyokaishi) 2003, 61,
262 (ꢂ1.7), 232 (ꢂ20.3), 205 (+18.7).
16. Selected spectral data for (S ,S,S,S
p
p
)-7: 1H NMR (400 MHz, CDCl
3
) d = ꢂ0.20 (m,
3
52–359.
0
)-5b: 1H NMR (270 MHz, CDCl
p p 3
2. Selected spectral data for (S ,3 S,S ) d = 0.13 (m,
2H), 0.21 (m, 2H), 0.31 (m, 2H), 0.45–0.60 (m, 6H), 0.60–0.75 (m, 4H), 0.75–
1.01 (m, 6H), 1.02–1.25 (m, 4H), 1.13 (s, 18H), 1.34 (m, 2H), 1.54 (m, 2H), 1.72
(m, 2H), 2.49–2.66 (m, 6H), 3.58 (ddd, J = 12.6, 6.9, 4.1 Hz, 2H), 4.36–4.48 (m,
4H), 4.81–4.89 (m, 2H), 7.83 (d, J = 2.4 Hz, 2H), 7.94 (t, J = 7.6 Hz, 1H), 8.09 (d,
J = 10.0 Hz, 2H), 8.26 (d, J = 7.6 Hz, 2H), 8.36 (d, J = 2.4 Hz, 2H); 13C NMR
1
1H), 0.35 (m, 1H), 0.38–0.90 (m, 16H), 0.95–1.29 (m, 8H), 1.31–1.48 (m, 4H),
1.10 (t, J = 7.8 Hz, 3H), 1.49–1.95 (m, 4H), 2.54–2.90 (m, 6H), 3.25 (ddd, J = 12.7,
6.8, 4.4 Hz, 1H), 3.75 (ddd, J = 10.7, 5.8, 4.4 Hz, 1H), 4.35–4.62 (m, 3H), 5.88 (d,
J = 7.4 Hz, 1H), 7.52 (d, J = 2.0 Hz, 1H), 7.97 (d, J = 2.4 Hz, 1H), 8.42 (d, J = 1.9 Hz,
3
(100 MHz, CDCl ) d = 24.4 (2C), 25.0 (2C), 26.1 (2C), 26.3 (2C), 26.7 (6C), 27.5
(2C), 27.6 (2C), 27.8 (2C), 28.1 (2C), 31.7 (2C), 34.3 (2C), 35.6 (2C), 57.4 (2C),
64.0 (2C), 125.1 (4C), 134.5 (2C), 138.8 (2C), 138.9, 148.5 (2C), 152.0 (2C), 161.2
1
3
1
1
3
2
2
H), 8.47 (d, J = 2.4 Hz, 1H); C NMR (68 MHz, CDCl
57.2, 152.1, 150.6, 138.8, 135.5, 134.7, 134.6, 131.8, 124.8, 77.2, 66.3, 50.7,
6.1, 35.1, 31.9, 31.8, 28.3, 28.2, 28.1, 27.82, 27.81, 27.7, 27.6, 27.5, 26.4, 26.38,
3
) d = 168.4, 166.8, 161.5,
(2C), 163.4 (2C), 167.2 (2C); CD (MeCN): kext = 285 (
D
e
+26.5), 262 (+10.1), 231
6.27, 25.24, 25.2, 24.8, 24.6, 24.4, 10.5; CD (CH
3
CN): kext = 283 (
D
e
+ 17.5),
(+51.5). For (S ,S,S,R
p
p
)-7: 1H NMR (400 MHz, CDCl
3
) d = ꢂ0.17 (m, 1H), ꢂ0.05
0
1
60 (+3.1), 230 (+33.3). For (S
p
,3 S,R
p
)-5b: H NMR (270 MHz, CDCl
3
) d = 0.13
(m, 1H), 0.20–0.45 (m, 4H), 0.45–0.65 (m, 10H), 0.80–1.02 (m, 6H), 1.02–1.20
(m, 4H), 1.13 (s, 9H), 1.14 (s, 9H), 1.30–1.35 (m, 2H), 1.51–1.57 (m, 2H), 1.69–
1.75 (m, 2H), 2.49–2.66 (m, 6H), 3.49–3.54 (m, 2H), 4.43–4.45 (m, 4H), 4.84–
4.90 (m, 2H), 7.80 (d, J = 2.4 Hz, 1H), 7.81 (d, J = 2.4 Hz, 1H), 7.94 (dd, J = 8.0,
(
3
m, 1H), 0.35 (m, 1H), 0.38–0.90 (m, 16H), 0.95–1.29 (m, 8H), 1.10 (t, J = 5.3 Hz,
H), 1.31–1.48 (m, 4H), 1.49–1.95 (m, 4H), 2.51–2.92 (m, 6H), 3.25 (ddd,
J = 12.7, 7.8, 4.4 Hz, 1H), 3.75 (ddd, J = 10.2, 6.3, 3.9 Hz, 1H), 4.42–4.59 (m, 3H),
.83 (d, J = 7.8 Hz, 1H), 7.44 (d, J = 2.0 Hz, 1H), 8.00 (d, J = 2.0 Hz, 1H), 8.40 (d,
5
7.6 Hz, 1H), 8.06 (d, J = 8.4 Hz, 1H), 8.08 (d, J = 9.6 Hz, 1H), 8.24 (d, J = 8.0 Hz,
1
3
13
J = 2.0 Hz, 1H), 8.46 (d, J = 2.0 Hz, 1H); C NMR (68 MHz, CDCl
3
) d = 168.2,
66.8, 161.2, 157.2, 151.9, 150.4, 138.7, 135.1, 134.5, 134.4, 131.4, 124.8, 77.0,
6.0, 50.5, 35.9, 34.9, 31.7, 31.6, 28.1, 28.0, 27.8, 27.7, 27.65, 27.6, 27.5, 27.4,
6.24, 26.23, 26.1, 25.1, 24.9, 24.6, 24.4, 24.2, 10.3; CD (CH CN): kext = 277
)-5b: H NMR (270 MHz,
) d = 0.13 (m, 1H), 0.35 (m, 1H), 0.38–0.90 (m, 16H), 0.95–1.29 (m, 8H),
1H), 8.25 (d, J = 7.6 Hz, 1H), 8.34 (d, J = 2.4 Hz, 1H), 8.36 (d, J = 2.4 Hz, 1H);
C
1
6
2
NMR (100 MHz, CDCl ) d = 24.2, 24.4, 25.2, 25.5, 26.0, 26.2, 26.5 (2C), 26.7 (3C),
3
26.9 (3C), 27.5, 27.6, 27.8, 27.9, 28.0, 28.1, 28.2 (2C), 31.5, 31.7, 34.1, 34.2, 35.8,
36.1, 57.1, 57.2, 64.0, 64.1, 124.8, 125.0, 129.8, 129.9, 133.0, 133.2, 134.5,
138.7, 138.8, 150.2, 150.5, 152.0, 152.4, 161.5, 161.6, 164.5, 164.9, 167.2,
3
0
p p
,3 S,S
1
(D
e
+ 2.1), 237 (ꢂ3.9), 208 (+11.7). For (R
CDCl
3
p p
167.6; CD (MeCN): kext = 285 (De +8.4), 270 (+4.6), 253 (+7.2). For (R ,S,S,R )-7:
1
1
3
4
1
.08 (t, J = 5.3 Hz, 3H), 1.31–1.48 (m, 4H), 1.49–1.95 (m, 4H), 2.54–2.90 (m, 6H),
.25 (ddd, J = 12.7, 8.8, 4.4 Hz, 1H), 3.75 (ddd, J = 10.2, 6.3, 3.9 Hz, 1H), 4.45–
.62 (m, 3H), 5.87 (d, J = 8.3 Hz, 1H), 7.51 (d, J = 2.5 Hz, 1H), 7.99 (d, J = 1.9 Hz,
H NMR (400 MHz, CDCl
3
) d = ꢂ0.08 (m, 2H), 0.25–0.40 (m, 4H), 0.50–0.60 (m,
6H), 0.67–0.75 (m, 4H), 0.80–0.95 (m, 6H), 1.00–1.20 (m, 4H), 1.12 (s, 18H),
1.20–1.39 (m, 4H), 1.55–1.68 (m, 4H), 2.47–2.58 (m, 4H), 2.64 (m, 2H), 3.51
(ddd, J = 12.6, 6.9, 4.1 Hz, 2H), 4.41–4.48 (m, 4H), 4.92 (m, 2H), 7.80 (d,
J = 2.3 Hz, 2H), 7.93 (t, J = 7.8 Hz, 1H), 8.03 (d, J = 10.0 Hz, 2H), 8.23 (d,
1
3
3
H), 8.42 (d, J = 2.5 Hz, 1H), 8.47 (d, J = 1.9 Hz, 1H); C NMR (68 MHz, CDCl )
d = 168.4, 167.0, 161.5, 157.6, 152.2, 150.6, 138.8, 135.1, 134.7, 134.5, 131.7,
1
2
24.8, 77.2, 66.3, 50.7, 36.2, 35.0, 31.9, 31.8, 28.3, 28.2, 28.0, 27.88, 27.85, 27.7,
7.5, 26.43, 26.4, 26.38, 26.3, 25.24, 25.2, 24.7, 24.6, 24.4, 10.5; CD (CH CN):
)-5b: H NMR (270 MHz,
) d = 0.13 (m, 1H), 0.35 (m, 1H), 0.38–0.90 (m, 16H), 0.95–1.29 (m, 8H),
J = 7.8 Hz, 2H), 8.34 (d, J = 2.3 Hz, 2H); 13C NMR (100 MHz, CDCl
3
) d = 24.4 (2C),
3
25.1 (2C), 26.2 (2C), 26.3 (2C), 26.7 (2C), 27.6 (6C), 27.8 (4C), 28.1 (2C), 31.7
(2C), 34.4 (2C), 35.9 (2C), 57.4 (2C), 63.9 (2C), 125.0 (4C), 134.3 (2C), 138.7 (2C),
138.9, 148.6 (2C), 151.8 (2C), 160.9 (2C), 163.7 (2C), 167.8 (2C); CD (MeCN):
0
p p
,3 S,R
1
kext = 280 (
D
e
ꢂ4.7), 240 (+2.6), 208 (ꢂ21.1). (R
CDCl
3
1
3
4
1
.05 (t, J = 6.9 Hz, 3H), 1.31–1.48 (m, 4H), 1.49–1.95 (m, 4H), 2.54–2.90 (m, 6H),
.25 (ddd, J = 12.7, 7.8, 3.9 Hz, 1H), 3.75 (ddd, J = 10.8, 6.9, 4.0 Hz, 1H), 4.55–
.62 (m, 3H), 5.88 (d, J = 7.8 Hz, 1H), 7.48 (d, J = 2.0 Hz, 1H), 8.03 (d, J = 2.0 Hz,
k
ext = 282 (
17. The final mixture after the heat isomerization consists of 87.7% of (S
11.5% of (S ,S,S,R )-7, and 0.8% of (R ,S,S,R )-7. The ratio was determined by
De ꢂ14.8), 259 (+3.9), 233 (ꢂ60.5).
p p
,S,S,S )-7,
p
p
p
p
1
3
H), 8.40 (d, J = 2.0 Hz, 1H), 8.47 (d, J = 2.4 Hz, 1H); C NMR (68 MHz, CDCl
3
)
HPLC analysis using CHIRALPAK IA, Dicel Chemical Industries, Ltd, with
hexane/ethyl acetate (2/1) as a mobile phase (flow rate: 1.0 mL/min; oven
temperature: 40 °C).
d = 168.5, 167.1, 161.5, 157.5, 152.2, 150.6, 138.9, 135.2, 134.7, 134.5, 131.8,
24.9, 77.2, 66.2, 50.7, 36.2, 35.0, 32.0, 31.9, 29.7, 28.3, 28.1, 27.88, 27.82, 27.7,
1